Michael Swartz

Practice Areas

Co-chair of the Litigation Group, head of the shareholder activism litigation practice and a member of the firm’s Executive Committee. Focuses on complex commercial litigation and antitrust, particularly as it relates to mergers and acquisitions. His litigation practice includes shareholder activist litigation, private investment fund disputes, M&A litigation, corporate control disputes and securities litigation, including class actions. Represented Trian Fund Management in the largest-ever proxy contest at Procter & Gamble, and achieved a series of victories on behalf of venBio Select Advisor in its proxy campaign at Immunomedics. Among other things, for venBio, obtained a TRO blocking the closing of a global license agreement, which effectively would have amounted to a sale of the company. Other recent litigation experience includes class actions, activist litigation; cryptocurrency investment fund disputes, representations of several boards and companies in M&A- and proxy-related litigation; and obtaining dismissal of several Section 16(b) actions seeking disgorgement of alleged short-swing trading profits from investment advisers and the funds they manage.

Personal

Columbia Law School, J.D., 1990

University of California, Los Angeles, B.A., magna cum laude, 1987